Subtle differences in molecular structure can have a major impact on the performance of mRNA-based drugs. The findings open ...

Summer heat, outdoor fun … and cold and flu symptoms? The three may not go together in many people’s minds: partly owing to ...

We’ll see another busy week for earnings , with reports also coming from BioNTech, GlobalFoundries, Rivia, Occidental, and ...

As the country continues to deal with the fallout of the infamous Jeffery Epstein files, The Root is taking a closer look at some of the most polarizing conspiracy theories in American history.

President Donald Trump’s tariffs continue to remain an overhang, with the market eyeing the Aug. 7 timeline when the revised ...

An industry-wide compensation scheme will cost lenders between £9bn and £18bn, the FCA says, reducing risk of larger bills ...

S&P 500 E-mini futures (ES) last traded at 6,288.25, bouncing after a two-day decline from the 7/31 high of 6,468.50.

India’s pharma sector is at a turning point transitioning from a global generics powerhouse to a serious contender in biotech ...

The expectation is that COVID-19 will eventually settle into a winter seasonal pattern like other coronaviruses, but the past few years have brought a late summer surge, said Dr. Dean Blumberg, chief ...

As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports ...

The company reported a net loss of $825 million for the quarter. Additionally, Moderna announced a $300 million reduction at the high end of their 2025 projected revenue range due to a timing shift of ...